BizJournals Portfolio

Dr. Steven M. Paul, M.D.

Executive Vice President, Science and Technology

Eli Lilly & Company (LLY)

Industry: Healthcare

Overview
News

Overview

Steven M. Paul, M.D., became executive vice president for science and technology in July 2003. He also is a member of the corporate policy committee and the company's senior management forum, a group of top Lilly executives who implements corporate strategies, ensures corporate performance and identifies corporate issues and opportunities. He joined Lilly in April 1993 as vice president of central nervous system discovery and decision phase medical research in LRL and was named vice president, therapeutic area discovery research and clinical investigation, in 1996. Paul became group vice president of therapeutic area discovery research and clinical investigation for LRL in 1998. Paul received a bachelor of arts degree, magna cum laude with honors, in biology and psychology from Tulane University in 1972. He received a master of science degree in anatomy and neuroanatomy and his doctor of medicine degree, both in 1975, from the Tulane University School of Medicine. Following an internship in neurology at Charity Hospital in New Orleans, he served as a resident in psychiatry and an instructor in the department of psychiatry at The University of Chicago, Pritzker School of Medicine. Prior to joining Lilly, Paul served as scientific director of the Intramural Research Program of the National Institute of Mental Health (NIMH), in Bethesda, Md.; professor of psychiatry at Tulane University School of Medicine; and chief of the clinical neuroscience branch, as well as chief of the section on preclinical studies at the National Institute of Mental Health (NIMH). Paul is a member of various professional societies, which include the Tulane Scholars and Fellows; Phi Eta Sigma; Alpha Epsilon Delta; Sigma Xi; Phi Beta Kappa; and the Alpha Omega Alpha Medical Society. He is the recipient of many honors and scientific recognitions, including the A.E. Bennett Award of the Society of Biological Psychiatry, the Foundations' Fund Prize for Research of the American Psychiatric Association and The Distinguished Service Medal of the United States. In 1997, Paul was elected to membership in the Institute of Medicine of the National Academy of Sciences. Paul has authored or co-authored more than 450 papers and invited book chapters and serves on the editorial boards of numerous scientific journals and as a grant reviewer for several extramural and intramural committees. He is currently a member of the National Institute of Health's advisory committee to the director (ACD). He has been listed as one of the most highly cited neuroscientists in the world (1980-2000) by the I.S.I., Philadelphia, Pa.


Real Business, Real Results

Did anyone at Microsoft ever watch the (gasp!) offensively funny show Family Guy?

Ex-Morgan Stanley exec Zoe Cruz is now heading her own hedge fund. Are Wall Street's leaders done?

Martha, Bernie and Skilling know that what you wear for court can go a long way in public perception.

spotlight on

Health Care

Bad to the Bone No More

Companies such as General Mills say they're stepping up efforts to change employees' bad behavior and promote healthier lifestyles. Read More